MediciNova, Inc. (TYO:4875)

Japan flag Japan · Delayed Price · Currency is JPY
190.00
-2.00 (-1.04%)
Jun 26, 2025, 3:19 PM JST
-14.80%
Market Cap 9.57B
Revenue (ttm) n/a
Net Income (ttm) -1.67B
Shares Out n/a
EPS (ttm) -34.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71,300
Average Volume 33,350
Open 191.00
Previous Close 192.00
Day's Range 189.00 - 196.00
52-Week Range 155.00 - 354.00
Beta n/a
RSI 36.15
Earnings Date Aug 13, 2025

About MediciNova

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 13
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4875
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.